Global Upper Extremities Treatment Products Industry

Global Upper Extremities Treatment Products Industry

  • April 2021 •
  • 373 pages •
  • Report ID: 5960374 •
  • Format: PDF
Abstract:
- Global Upper Extremities Treatment Products Market to Reach $6.6 Billion by 2027
- Amid the COVID-19 crisis, the global market for Upper Extremities Treatment Products estimated at US$4.4 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Braces and Supporting Systems, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Orthobiologics segment is readjusted to a revised 5.5% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 9% CAGR
- The Upper Extremities Treatment Products market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
- Accessories Segment to Record 4.9% CAGR
- In the global Accessories segment, USA, Canada, Japan, China and Europe will drive the 4.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$882.2 Million by the year 2027, while Latin America will expand at a 6% CAGR through the analysis period.

- Select Competitors (Total 46 Featured) -
  • Acumed LLC
  • Arthrex, Inc.
  • Avitus Orthopaedics, Inc.
  • Bioservo Technologies AB
  • Biotech Limb and Brace LLC
  • Bioventus LLC
  • Bone Biologics Corp.
  • Bone Therapeutics SA
  • Ceramisys Ltd.
  • Collplant Holdings Ltd.
  • ConMed Corporation
  • DePuy Synthes
  • DJO Global, Inc.
  • EVOLUTIS SAS
  • Exactech, Inc.
  • FH Orthopedics SAS
  • FX Solutions
  • Graftys SAS
  • ICONACY Orthopedic Implants, LLC
  • implantcast GmbH
  • Integra Lifesciences Corporation
  • Isto Biologics
  • Limacorporate S.p.A.
  • Medtronic PLC
  • Merete GmbH
  • Myomo, Inc.
  • NovaBone Products LLC
  • Orthofix
  • Orthogen
  • Ossur
  • Osteomed L.P.
  • Promedics Orthopaedic Ltd.
  • Regenexx
  • RTI Surgical, Inc.
  • SigmaGraft, Inc.
  • Silver Bullet Therapeutics, Inc.
  • Skeletal Dynamics LLC
  • Smith & Nephew PLC
  • Stanmore Implants
  • Stryker Corporation
  • Surgical Appliance Industries
  • Tri-Med
  • Wright Medical
  • Xtant Medical
  • Zimmer Biomet Holdings, Inc.